{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:49:34Z","timestamp":1786650574252,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0253-7613.108319","type":"journal-article","created":{"date-parts":[[2013,3,11]],"date-time":"2013-03-11T02:07:02Z","timestamp":1362967622000},"page":"191","source":"Crossref","is-referenced-by-count":13,"title":["Tenofovir induced Fanconi syndrome: A possible pharmacokinetic interaction"],"prefix":"10.4103","volume":"45","author":[{"given":"Samidh","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigar","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AshaN","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RK","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.108319-1","unstructured":"Flexner C. Antiretroviral agents and treatment of HIV infection. The pharmacological Basis of Therapeutics. 11 th ed. New York: McGraw Hill; 2006. p. 1290-1."},{"key":"key-10.4103\/0253-7613.108319-2","first-page":"C3","volume-title":"Acquired Fanconi\u2032s syndrome associated with tenofovir therapy","author":"Mathew","year":"2006","journal-title":"J Gen Intern Med"},{"key":"key-10.4103\/0253-7613.108319-3","first-page":"e174","volume-title":"Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: The role of lopinavir-ritonavir-didanosine","author":"Rollot","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0253-7613.108319-4","unstructured":"Asplin JR, Coe FL. Tubular disorders. In: Kasper D, Braunwald E, Fauci A, Hauser S, Longo D, Jameson J, editors. Harrison\u2032s Principles of Internal Medicine. 16 th ed. New York: McGraw Hill; 2005. p. 1701."},{"key":"key-10.4103\/0253-7613.108319-5","unstructured":"Who-umc.org. The Uppsala Monitoring Centre. Available from: http:\/\/www.who-umc.org\/DynPage.aspx?id=22682. [Last accessed 2010 sep 24]."},{"key":"key-10.4103\/0253-7613.108319-6","first-page":"239","volume-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clinical Pharmacology & Therapeutics,"},{"key":"key-10.4103\/0253-7613.108319-7","first-page":"2229","volume-title":"Preventability and severity assessment in reporting adverse drug reactions","author":"Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"key-10.4103\/0253-7613.108319-8","first-page":"538","volume-title":"Focusing on the preventability of adverse drug reactions","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"key":"key-10.4103\/0253-7613.108319-9","first-page":"283","volume-title":"Tenofovir-associated acute and chronic kidney disease: A case of multiple drug interactions","author":"Zimmermann","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0253-7613.108319-10","first-page":"30","volume-title":"Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India","author":"Patel","year":"2010","journal-title":"Indian J Sex Transm Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7184","issn-type":"print"},{"key":"key-10.4103\/0253-7613.108319-11","first-page":"102","volume-title":"Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.Journal of Infectious Diseases","author":"Goicoechea","year":"2008","journal-title":""},{"key":"key-10.4103\/0253-7613.108319-12","first-page":"3361","volume-title":"Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy","author":"Jullien","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:20:29Z","timestamp":1786648829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.108319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"alternative-id":["108319"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.108319","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}